Función barrera intestinal y saludDiscurso de Ingreso como Académica de Número en la Real Academia de Ciencias Veterinarias de Andalucía Oriental

Referencias bibliográficas

• Araya, M., Bascuñán, K. (2014). Enfermedad celíaca. Una mirada actual. Revista Chilena de Pediatría, 85(6), 658-665.
• Bellmann, S., Carlander, D., Fasano, A., Momcilovic, D., Scimeca, J. A., Waldman, W. J., Gombau, L., Tsytsikova, L., Canady, R, Pereira, D,I.A., Lefebvre, D. E. (2015). Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 7(5), 609-622
• Breton J, Tennoune N, Lucas N, Francois M, Legrand R, Jacquemot J, Goichon A, Guerin C, Peltier J, Pestel-Caron M, et al: Gut Commensal E. coli Proteins Activate Host Satiety Pathways following Nutrient-Induced Bacterial Growth. Cell Metab 2016, 23:324-334.
• Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino J.F., Costa-Mattioli, M. (2016). Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell, 165:1762-1775.
• Camilleri, M., Madsen, K., Spiller, R., Van Meerveld, B. G., Verne, G. N. (2012). Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterology & Motility, 24(6), 503- 512.
• Carné, S., Zaragoza, A. (2014). B-Galactomananos vegetales hidrolizados para prevenir la invasión intestinal de Salmonella en avicultura: Publirreportaje. Seleccionesavícolas, 56(9), 37-41.
• Cian, R.E., Drago, S.R., Sánchez de Medina, F., Martínez-Augustin, O. Proteins and Carbohydrates from Red Seaweeds: Evidence for Beneficial Effects on Gut Function and Microbiota. Mar. Drugs 2015, 13, 5358-5383; doi:10.3390/md13085358
• Chen, J., Tellez, G., Richards, J. D., Escobar, J. (2015). Identification of potential biomarkers for gut barrier failure in broiler chickens. Frontiers in Veterinary Science, 2. Sanchez de Medina F., Romero-Calvo I., Mascaraque C., Martinez-Augustin O. (2014). Intestinal inflammation and mucosal barrier function. Inflamm. Bowel Dis. 2014;20:2394–2404
• De Medina, F., Ortega-González, M., González-Pérez, R., Capitán-Cañadas, F., Martínez-Augustin, O. (2013). Host–microbe interactions: The difficult yet peaceful coexistence of the microbiota and the intestinal mucosa. British Journal of Nutrition, 109(S2), S12-S20. doi:10.1017/S0007114512004035
• Evrensel, A., Ceylan, M. E. (2016). Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clinical Psychopharmacology and Neuroscience, 14(3), 231.
• Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological Reviews, 91(1), 151-175.
• Fadini, G. P., Menegazzo, L., Scattolini, V., Gintoli, M., Albiero, M., Avogaro, A. (2016). A perspective on NETosis in diabetes and cardiometabolic disorders. Nutrition, Metabolism and Cardiovascular Diseases, 26(1), 1-8.
• Fasano, A. (2008). Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. The American Journal of Pathology, 173(5), 1243-1252.
• Groen, A. K., Nieuwdorp, M. (2016). An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases. EMBO Molecular Medicine, e201607035.
• Groschwitz, K. R., Hogan, S. P. (2009). Intestinal barrier function: molecular regulation and disease pathogenesis. Journal of Allergy and Clinical Immunology, 124(1), 3-20.
• Halmos, T., Suba, I. (2016). Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic síndrome. Orvosi Hetilap, 157(1), 13-22.
• Hollon, J., Puppa, E. L., Greenwald, B., Goldberg, E., Guerrerio, A., Fasano, A. (2015). Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients, 7(3), 1565-1576.
• Honda, K., & Littman, D. R. (2016). The microbiota in adaptive immune homeostasis and disease. Nature, 535(7610), 75-84.
• Hudson, L. E., Anderson, S. E, Corbett, A. H., Lamb, T. J. (2017). Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clinical Microbiology Reviews, 30(1), 191-231.
• Lynch, S. V., Pedersen, O. The Human Intestinal Microbiome in Health and Disease (2016). N Engl J Med 2016; 375:2369-2379 DOI: 10.1056/NEJMra1600266
• Marjoram, L., Alvers, A., Deerhake, M.E., Bagwell, J., Mankiewicz, J., Cocchiaro, J.L., Beerman, R.W., Willer, J., Sumigray, K.D., Katsanis, N., Tobin, D.M., Rawls, J.F., Goll, M.G., Bagnat, M. (2015). Epigenetic control of intestinal barrier function and inflammation in zebrafish. Proceedings of the National Academy of Sciences, 112(9), 2770-2775.
• Marotz, C. A., Zarrinpar, A. (2016). Focus: Microbiome: Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. The Yale Journal of Biology and Medicine, 89(3), 383.
• Martínez-Augustin, O., Rivero-Gutiérrez, B., Mascaraque, C., Sánchez de Medina, F. (2014). Food derived bioactive peptides and intestinal barrier function. International Journal of Molecular Sciences, 15(12), 22857-22873.
• Martinez-Augustin, O., Daddaoua, A., Requena, P., Capitán-Cañadas, F., Suárez, M.D., Zarzuelo, A., Sánchez de Medina, F. (2011). Nueva percepción de los efectos inmunológicos de los péptidos bioactivos alimenticios en modelos animales de inflamación intestinal. En: Inmunonutrición en la salud y en la enfermedad. Ascensión Marcos, ED. Editorial Panamericana Madrid. ISBN: 978-84-9835-402-7, 590- 601. (2011).
• Nouri, M., Bredberg, A., Weström, B., Lavasani, S. (2014). Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS One 9(9): e106335.
• Odenwald, M. A., & Turner, J. R. (2016). The intestinal epithelial barrier: a therapeutic target? Nature Reviews Gastroenterology & Hepatology.
• Ohland, C. L., & MacNaughton, W. K. (2010). Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology-Gastrointestinal and Liver Physiology, 298(6), G807- G819.
• Onrust, L., Ducatelle, R., Van Driessche, K., De Maesschalck, C., Vermeulen, K., Haesebrouck, F., Eeckhaut, V., Van Immerseel, F. (2015). Steering endogenous butyrate production in the intestinal tract of broilers as a tool to improve gut health. Front Vet Sci. 2: 75.
• Pérez-Bosque, A., Miró, L., Maijó, M., Polo, J., Campbell, J. M., Russell, L., Crenshaw, J.D., Weaver, E., Moretó, M. (2016). Oral Serum-Derived Bovine Immunoglobulin/Protein PLoS One , 11(5), e0154823
• Pérez-Bosque, A., Miró, L., Amat, C., Polo, J., Moretó, M. (2016). The Anti-Inflammatory Effect of Spray-Dried Plasma Is Mediated by a Reduction in Mucosal Lymphocyte Activation and Infiltration in a Mouse Model of Intestinal Inflammation. Nutrients, 8(10), 657.
• Pearce S C, Mani V, Boddicker R L, Johnson J S, Weber T E, Ross JW, Rhoads RP, Lance H. Baumgard1, Nicholas K. Gabler N K. (2013). Heat stress reduces intestinal barrier integrity and favors intestinal glucose transport in growing pigs. PLoS One, 8(8), e70215.
• Peterson, L. W., &Artis, D. (2014). Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol, 14(3), 141-53.
• Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., Theoharides, T. C. (2015). Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clinical Therapeutics, 37(5), 984-995.
• Robinson K, Deng Z, Hou, Y, Zhang G. (2015). Regulation of the intestinal barrier function by host defense peptides. Front Vet Sci, 2.
• Rodriguez H. (2016) De tristeza microbiológica y prozacs bacterianos. Principia (Blog) 5 Diciembre 2016
• Ruggiero, M. Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases. Clin. Endosc. 2016;49(6):579-579.
• Salvo-Romero, E., Alonso-Cotoner, C., Pardo-Camacho, C., Casado-Bedmar, M., Vicario, M. Función barrera intestinal y su implicación en enfermedades digestivas. Rev. EspEnfermDig (Madrid)Vol. 107, N.º 11, pp. 686-696, 2015
• Schulz, M.D., Atay, Ç., Heringer, J., Romrig, F.K., Schwitalla, S., Aydin, B., Ziegler, P.K., Varga, J., Reindl, W., Pommerenke, C., Salinas-Riester, G., Böck, A., Alpert, C., Blaut, M., Polson, S.C., Brandl, L., Kirchner, T., Greten, F.R., Shawn W. Polson, S.W., Arkan, M.C. (2014). High-fatdiet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature, 514(7523), 508-512.
• Sonnenburg, J L, Bäckhed F. (2016). Diet-microbiota interactions as moderators of human metabolism. Nature, 535(7610), 56-64.
• Sonnenburg, J L, Bäckhed F. (2016). Diet-microbiota interactions as moderators of human metabolism. Nature, 535(7610), 56-64.
• Thaiss, C. A., Zmora, N., Levy, M., Elinav, E. (2016).The microbiome and innate immunity. Nature, 535(7610), 65-74.
• Tremaroli,V., Bäckhed, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature, 489(7415), 242-249.
• Webb, C. R., Koboziev, I., Furr, K. L., Grisham, M. B. (2016). Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology, 23(2), 67-80.
• Xu, M. Q., Cao, H. L., Wang, W. Q., Wang, S., Cao, X. C., Yan, F., & Wang, B. M. (2015). Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol, 21(1), 102-11
• Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., Hsiao, E.Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161:264-276